{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:53:32Z","timestamp":1779000812322,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.msard.2025.106558","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:51:34Z","timestamp":1748638294000},"page":"106558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Refining outcome measures in multiple sclerosis clinical trials: A call to action"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2821-9042","authenticated-orcid":false,"given":"Bruno","family":"Kusznir Vitturi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106558_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103144","article-title":"Lebrun-Fr\u00e9nay C. Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability","volume":"54","author":"Cohen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2025.106558_bib0002","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40263-024-01066-3","article-title":"Real-world retrospective analysis of Alemtuzumab outcomes in relapsing-remitting multiple sclerosis: the LEMCAM study","volume":"38","author":"Costa-Frossard","year":"2024","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.msard.2025.106558_bib0001","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of Multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.msard.2025.106558_bib0008","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nic.2024.03.004","article-title":"New imaging markers in multiple sclerosis and related disorders: smoldering inflammation and the Central vein sign","volume":"34","author":"Hemond","year":"2024","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"2","key":"10.1016\/j.msard.2025.106558_bib0003","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00415-023-11943-4","article-title":"Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension","volume":"271","author":"Kappos","year":"2024","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106558_bib0004","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","article-title":"Harmonizing definitions for progression independent of relapse activity in Multiple sclerosis: a systematic review","volume":"80","author":"M\u00fcller","year":"2023","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106558_bib0005","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/jnnp.2008.145805","article-title":"UBCMS Clinic Neurologists. Relapses in multiple sclerosis are age- and time-dependent","volume":"79","author":"Tremlett","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.msard.2025.106558_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272156","article-title":"Spatial and temporal distribution of unemployement and early retirement in people with multiple sclerosis: A systematic review with meta-analysis","volume":"17","author":"Vitturi","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msard.2025.106558_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210121","article-title":"Neuroimaging correlates of 3 distinct physical-cognitive phenotypes in cognitively normal older adults: the Gothenburg H70 cohort study","volume":"104","author":"Wang","year":"2025","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T23:12:01Z","timestamp":1754003521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":9,"alternative-id":["S2211034825003001"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106558","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining outcome measures in multiple sclerosis clinical trials: A call to action","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106558"}}